West Pharmaceutical Services Research and Development Expenses 2010-2024 | WST

West Pharmaceutical Services annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • West Pharmaceutical Services research and development expenses for the quarter ending December 31, 2024 were $0.019B, a 0.54% increase year-over-year.
  • West Pharmaceutical Services research and development expenses for the twelve months ending December 31, 2024 were $0.069B, a 1.02% increase year-over-year.
  • West Pharmaceutical Services annual research and development expenses for 2024 were $0.069B, a 1.02% increase from 2023.
  • West Pharmaceutical Services annual research and development expenses for 2023 were $0.068B, a 16.92% increase from 2022.
  • West Pharmaceutical Services annual research and development expenses for 2022 were $0.059B, a 10.8% increase from 2021.
West Pharmaceutical Services Annual Research and Development Expenses
(Millions of US $)
2024 $69
2023 $68
2022 $59
2021 $53
2020 $47
2019 $39
2018 $40
2017 $39
2016 $37
2015 $34
2014 $37
2013 $38
2012 $33
2011 $29
2010 $24
2009 $20
West Pharmaceutical Services Quarterly Research and Development Expenses
(Millions of US $)
2024-12-31 $19
2024-09-30 $16
2024-06-30 $18
2024-03-31 $18
2023-12-31 $18
2023-09-30 $16
2023-06-30 $17
2023-03-31 $17
2022-12-31 $16
2022-09-30 $14
2022-06-30 $14
2022-03-31 $15
2021-12-31 $14
2021-09-30 $13
2021-06-30 $14
2021-03-31 $12
2020-12-31 $13
2020-09-30 $13
2020-06-30 $11
2020-03-31 $11
2019-12-31 $10
2019-09-30 $9
2019-06-30 $10
2019-03-31 $10
2018-12-31 $10
2018-09-30 $10
2018-06-30 $11
2018-03-31 $10
2017-12-31 $10
2017-09-30 $9
2017-06-30 $10
2017-03-31 $10
2016-12-31 $10
2016-09-30 $9
2016-06-30 $9
2016-03-31 $9
2015-12-31 $10
2015-09-30 $9
2015-06-30 $8
2015-03-31 $8
2014-12-31 $8
2014-09-30 $10
2014-06-30 $10
2014-03-31 $10
2013-12-31 $10
2013-09-30 $10
2013-06-30 $10
2013-03-31 $9
2012-12-31 $9
2012-09-30 $8
2012-06-30 $8
2012-03-31 $8
2011-12-31 $7
2011-09-30 $8
2011-06-30 $7
2011-03-31 $7
2010-12-31 $7
2010-09-30 $6
2010-06-30 $6
2010-03-31 $5
2009-12-31 $6
2009-09-30 $5
2009-06-30 $5
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.185B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $84.343B 23.08
Becton Dickinson (BDX) United States $65.771B 16.47
Cardinal Health (CAH) United States $33.281B 17.82
Labcorp (LH) United States $19.480B 15.97
Straumann Holding AG (SAUHY) Switzerland $19.198B 0.00
Cooper (COO) United States $16.868B 22.37
Align Technology (ALGN) United States $11.630B 22.53
Henry Schein (HSIC) United States $8.505B 14.45
Merit Medical Systems (MMSI) United States $6.219B 30.38
DENTSPLY SIRONA (XRAY) United States $2.973B 8.95
Patterson (PDCO) United States $2.764B 15.94
CONMED (CNMD) United States $1.867B 14.52
STAAR Surgical (STAA) United States $0.870B 0.00
Lifevantage (LFVN) United States $0.183B 20.25
Pro-Dex (PDEX) United States $0.162B 24.67